Search companies

Live

Tuesday, 17 November 2026 · 582 Summaries Today

S&P/ASX 200 · 8,883.20 (-1.79%)

Australian Clinical Labs shares jump as shareholders back AGM resolutions

ACL: $3.15 +6.42% · MC: $619M

Australian Clinical Labs shares jumped about 7% to $3.17 in afternoon trading as shareholders approved all resolutions at the pathology provider’s annual meeting. The vote included the appointment of Deloitte as auditor, performance rights for chief executive Greg Horan and renewal of proportional takeover provisions.

Separate substantial-holder notices showed Commonwealth Bank of Australia’s voting power fell to about 7% from over 8%, while Superannuation and Investments HoldCo reported a similar decline. The notices describe overlapping relevant interests, including interests held through a superannuation trustee and a managed investment scheme; the supplied excerpts do not establish the transactions behind the changes.

Source announcements: 2026-10-28 12:26 to 2026-10-28 15:47 Sydney time
Story updated 2026-10-28 16:13 Sydney time
SourcesChange in substantial holding2026 AGM - Chair and CEO AddressesChange in substantial holding from CBA2026 AGM - Voting Results
Comments